Contact Us
brand-story1

Evolving Science, Fulfilling Lives

Innovation. Empowerment. Shared Values.

EffePharm is a pioneering biotech company dedicated to providing science-backed bioactive ingredients that address unmet nutritional needs. We empower individuals to take control of their health and achieve success at every stage of life by delivering advanced wellness solutions to users around the globe, driven by the belief that everyone should have equal access to health and nutrition.

As an expert in numerous categories, EffePharm leads industry trends in product iteration and resource integration. Our innovative capabilities span healthy aging, human nutrition, personal care, and more. Our Effe-PLUS platform harnesses the potential of a wide range of active ingredients.

Our products
  • 6281534

    st

    Uthever® 1st World's First Clinically-Proven Bulk NMN Brand
    No.1 Trademarketed Brand in the US*
  • 2977989

    st

    UthPeak® 1st Clinically Proven & Self-GRAS Approved Reduced NMN
  • 7921213

    +

    20+ Invention patents & International patents
组11

Global Partnership

EffePharm is committed to delivering efficacy-verified products backed by solid scientific evidence, positively impacting millions of consumers worldwide. We provide clinically backed, scientifically validated, 100% traceable ingredients to over 3,000 business partners globally. Our “Uth” series trademarks are licensed to over 110 consumer brands. Through innovative solutions and a dedication to quality, EffePharm continues to enhance health and well-being worldwide.

音芙全球合作伙伴
  • 7565658

    +

    Sell products to 50+ countries worldwide
  • 11182636

    +

    License the "Uth" series trademarks to over 110+ consumer brands worldwide
  • 11808776

    +

    Provide health solutions for 3000+ clients worldwide

Our History

  • brand-story6
    Launch of EffePharm Lab.
    Launch of Uthever®, Biofolate®.
    2017
  • brand-story5
    Improved NMN salt structure for better stability.
    2018
  • brand-story4
    Started NMN toxicology study.
    2019
  • brand-story3
    Launched biomedical R&D center.
    Achieved exponential productivity increase on NMN.
    2020
  • glutathione1
    Uthever® is the first NMN brand to conduct a large-scale clinical study in the world.
    2021
  • Man Running Toward Sunset in Field of Tall Grass
    UthPeak® NMNH crystal-form patent applied and toxicological research completed.
    2022
  • Q10-4
    Officially launched the Effe-PLUS platform.
    Pending application for Novel Food (EU).
    2023
  • Cosmetic3
    UthPeak® NMNH started phase I clinical trials.
    2024
  • nmnh1
    UthPeak® NMNH phase II clinical trial scheduled.
    2025
  • 2017
  • 2018
  • 2019
  • 2020
  • 2021
  • 2022
  • 2023
  • 2024
  • 2025

Our Products

Why Partner with EffePharm
Innovation. Empowerment. Shared Values.

At EffePharm, we don’t just manufacture ingredients; we engineer health-forward solutions that push the boundaries of modern biotechnology. As a global NAD+ manufacturer, we’re proud to lead the field with clinically backed, scientifically validated innovations that serve both people and purpose.

Our mission has continually been to empower both the brands and consumers alike with the use of science that can be trusted. The first clinically proven bulk NMN was our innovation, which we still practice today, and we are still investing in the next generation of delivery systems, such as the liposomal and microencapsulation platforms. We confirm every decision we have made through efficacy, safety, and the long-term impact those decisions may have.

Being a responsible NAD+ manufacturer means more than production; it means accountability. That’s why our ingredients are 100% traceable, our research is peer-reviewed, and our partnerships are built to last. Whether it’s supporting healthy aging or improving cellular resilience, we create with care and with vision.

Join us as we continue to evolve science and fulfill lives.

+86(021)5770 9202
deal@effepharm.com
Contact Us
Need live support?
Chat with us now